Applied Molecular Transport to Present at Upcoming June Investor Conferences

Rhea-AI Summary

Applied Molecular Transport Inc. (Nasdaq: AMTI) will participate in two key investor conferences in June 2022. The company will present at the Jefferies Global Healthcare Conference on June 9 at 8:30 a.m. ET, featuring CEO Tahir Mahmood. Additionally, they will present at the JMP Securities 2022 Life Sciences Conference on June 15 at 1:00 p.m. ET, with presentations by COO Shawn Cross and CMO Bittoo Kanwar. Live webcasts and archived replays will be available on the company's website, providing insights into their oral biologic product candidates and innovative technology.

SOUTH SAN FRANCISCO, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced its participation in fireside chats at the following investor conferences:

Event: Jefferies Global Healthcare Conference
Presentation Date & Time: Thursday, June 9, 2022, at 8:30 a.m. ET
Location: New York, New York
Presenter: Tahir Mahmood, Ph.D., chief executive officer and co-founder

Event: JMP Securities 2022 Life Sciences Conference
Presentation Date & Time:   Wednesday, June 15, 2022, at 1:00 p.m. ET
Location: New York, New York
Presenters: Shawn Cross, president and chief operating officer, and Bittoo Kanwar, M.D., chief medical officer

Live webcasts will be accessible via the Events page of the Applied Molecular Transport website at https://ir.appliedmt.com/news-events/events. Archived replays will be available for 30 days following the events.

About Applied Molecular Transport Inc.
AMT is a clinical-stage biopharmaceutical company developing novel oral biologic product candidates, by leveraging its technology platform to design biologic product candidates in patient friendly oral dosage forms. AMT’s product candidates are designed to precisely target the relevant pathophysiology of disease. AMT’s proprietary technology platform is incorporated in its product candidates, exploiting existing natural cellular trafficking pathways to drive the active transport of diverse therapeutic modalities across the IE barrier. Active transport is an efficient mechanism that utilizes the cell’s own machinery to transport materials across the IE barrier.

AMT’s headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA. For additional information on AMT, please visit www.appliedmt.com. 

Investor Relations Contact:
Andrew Chang
Head, Investor Relations & Corporate Communications
achang@appliedmt.com

Media Contacts:
Alexandra Santos
Wheelhouse Life Science Advisors
asantos@wheelhouselsa.com

Aljanae Reynolds
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com

 

FAQ

What events will Applied Molecular Transport Inc. participate in June 2022?

AMTI will participate in the Jefferies Global Healthcare Conference on June 9 and the JMP Securities 2022 Life Sciences Conference on June 15.

Who will present at the Jefferies Global Healthcare Conference for AMTI?

Tahir Mahmood, Ph.D., the CEO, will present at the Jefferies Global Healthcare Conference on June 9, 2022.

What is the date and time of AMTI's presentation at the JMP Securities 2022 Life Sciences Conference?

AMTI will present at the JMP Securities 2022 Life Sciences Conference on June 15, 2022, at 1:00 p.m. ET.

Where can investors access the live webcasts for AMTI's presentations?

Live webcasts for AMTI's presentations will be available on the company's Events page on their website.

What is the focus of Applied Molecular Transport Inc.'s product candidates?

AMTI focuses on developing oral biologic product candidates that target the pathophysiology of diseases using their proprietary technology.